Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP873512.RAvprPeRqdyvYpM1HnBLRshwDkYVrPzGTOuUNClL1UicE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP873512.RAvprPeRqdyvYpM1HnBLRshwDkYVrPzGTOuUNClL1UicE130_assertion type Assertion NP873512.RAvprPeRqdyvYpM1HnBLRshwDkYVrPzGTOuUNClL1UicE130_head.
- NP873512.RAvprPeRqdyvYpM1HnBLRshwDkYVrPzGTOuUNClL1UicE130_assertion description "[Treatment with high-dose bolus IL-2 mediates complete cancer regression in approximately 8% of patients with metastatic renal cancer and melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873512.RAvprPeRqdyvYpM1HnBLRshwDkYVrPzGTOuUNClL1UicE130_provenance.
- NP873512.RAvprPeRqdyvYpM1HnBLRshwDkYVrPzGTOuUNClL1UicE130_assertion evidence source_evidence_literature NP873512.RAvprPeRqdyvYpM1HnBLRshwDkYVrPzGTOuUNClL1UicE130_provenance.
- NP873512.RAvprPeRqdyvYpM1HnBLRshwDkYVrPzGTOuUNClL1UicE130_assertion SIO_000772 9742914 NP873512.RAvprPeRqdyvYpM1HnBLRshwDkYVrPzGTOuUNClL1UicE130_provenance.
- NP873512.RAvprPeRqdyvYpM1HnBLRshwDkYVrPzGTOuUNClL1UicE130_assertion wasDerivedFrom befree-20140225 NP873512.RAvprPeRqdyvYpM1HnBLRshwDkYVrPzGTOuUNClL1UicE130_provenance.
- NP873512.RAvprPeRqdyvYpM1HnBLRshwDkYVrPzGTOuUNClL1UicE130_assertion wasGeneratedBy ECO_0000203 NP873512.RAvprPeRqdyvYpM1HnBLRshwDkYVrPzGTOuUNClL1UicE130_provenance.